Stents for Heart Failure With Normal Pumping
Part of Heart & circulation clinical trials.
This trial tests whether placing stents in coronary arteries helps patients with heart failure who still have a strong-pumping heart. The study aims to see if improving blood flow to the heart reduces symptoms and improves quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with HFpEF (heart failure with preserved ejection fraction) by European Society of Cardiology criteria
- Heart failure symptoms (NYHA class II–IV, ranging from mild to severe)
- Left ventricular ejection fraction of 50% or higher (your heart pumps at least half its blood with each beat)
- Elevated NT-pro-BNP blood marker (125+ pg/ml in normal rhythm or 365+ pg/ml if you have atrial fibrillation)
- Evidence of diastolic dysfunction (stiffness in the heart's lower chamber) on imaging or pressure measurements
- Age 18 or older, able to understand and consent to the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people who have heart failure symptoms but whose heart pumping strength is largely preserved. It aims to better understand this specific type of heart failure and how best to treat or evaluate it.
This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.
This study looks at people with a type of heart failure where the heart pumps normally but still doesn't fill properly. Researchers are using ultrasound pictures of the heart (echocardiograms) and blood tests to better understand this condition and find better ways to treat it.
This study looks for people who may have heart failure with preserved pumping function, where the heart is stiff and doesn't fill properly. It aims to better understand and identify this condition to improve care.
This trial compares two ways to restore blood flow to the heart—bypass surgery (CABG) or stents (PCI)—in people whose heart pumps weakly (LVEF 40% or less). It aims to find which method works better for chest pain or recent heart issues.
This study compares two ways to improve blood flow in people with weakened heart pumping (ischemic cardiomyopathy): bypass surgery (CABG) versus stent treatment (PCI). It aims to see which approach works better when the heart still has enough at-risk muscle and when best medical therapy is already started.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.